SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 18, 2020

SIBANNAC, INC.

(Exact name of registrant as specified in its charter)

Nevada	333-122009	33-0903494
(State or other jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification Number)

9535 E Doubletree Ranch Road, Ste 120

Scottsdale, AZ 85258

Tel. (480) 407-6445

(Address and Telephone Number of Principal Executive Offices)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value	N/A	N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b 2 of this chapter). Emerging growth company ☐

If any emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

SIBANNAC, INC.

Form 8-K

Current Report

item 1.01

entry into a material definitive agreement

The Company has entered into a non-binding Memorandum of Understanding to acquire 51% ownership of a twenty-year old firm in the Apricot Seed processing and consumer sales business. Apricots contain high amounts of naturally occurring Vitamin B-17. Through a third-party farming conglomerate, the target company has an exclusive contractual right to nearly the entire offtake of domestically grown Apricot seeds in the United States.

ITEM 4.01

mATTERS RELATED TO ACCOUNTANTS AND FINANCIAL STATEMENTS

The Company has engaged the firm of Semple, Marchal & Cooper, LLP, as its independent Auditor. The firm is located at 2700 North Central Avenue, 9^th Floor, Phoenix, AZ 85004.

The books and records of the company are being forwarded to the firm to audit the current financial statements, which is anticipated to be completed and the audit published by the end of the third quarter.

ITEM 5.02

DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN DIRECTORS

The Company is proud to announce the addition of two new members of the Board of Directors:

James D. Staudohar

James D. Staudohar is a veteran of corporate finance, having served in senior management for successful public companies and private enterprise. In addition to serving on the Board, Mr. Staudohar will chair the Company’s Audit Committee.

Mr. Staudohar has served in senior financial positions for Honeywell, Control Data Corp. and the Dayton Hudson Corporation. He was Vice President and Controller of B. Dalton Booksellers and its 750 stores and held the same positions for Modern Merchandising. Jim has served as CFO of several companies, perhaps most notably as Senior Vice President and Chief Financial Officer of Best Products, then a $5 billion firm listed on the NYSE.

In addition to his financial experience, Mr. Staudohar has served on the Board of Directors, as Chair of the Audit Committee, and as a member of the Compensation Committee of Iveda Solutions, Inc. He previously served on the Board of Directors of Smith & Wesson Holding Corporation, the publicly traded parent company of the gun manufacturer, from 2002-2004. He also served as the Chair of Smith & Wesson’s Audit Committee and as a member of the Nominating Committee. Mr. Staudohar received his B.A. Degree in Accounting from the University of Minnesota.

Mr. Staudohar has also served as President of Ballet Arizona, and as a board member of Phoenix Sister Cities and as a volunteer of the Mayo Clinic.

Booker T. Evans, Jr.

Mr. Evans is a renowned trial attorney, having been a member of some of the leading law firms in the country over one of the most distinguished legal careers. Mr. Evan’s practice has been concentrated in commercial litigation and white- collar criminal defense, product liability, insurance matters, criminal and civil RICO cases, and health law matters. Booker has substantial civil and criminal trial experience, along with post-conviction case experience in the federal court system and is often retained in matters involving the Federal Sentencing Guidelines.

He has been named to Arizona's Finest Lawyers, a Southwest Super Lawyer in Arizona, a Top 50 Super Lawyer and a Super Lawyer in White Collar Criminal Defense, a Top 100 Trial Lawyer and a Best Lawyer in America by US News & World Report.

Prior to entering private practice, he served as a Chief Deputy District Attorney in Las Vegas, Assistant United States Attorney in Nevada and Arizona, and Corporate Counsel for Arizona Public Service Company.

ITEM 5.03

AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.

The Company has filed Amendments to the Articles of Incorporation with the State of Nevada, providing designations for the Preferred Class A shares as well as creating a Preferred Class B. The designations are annexed as Exhibit A. The Company is in the process of rolling back the authorized common shares with the State of Nevada to 60,000,000, the issuance as of the date of acquisition of Imbutek Holdings in July 2017.

ITEM 8.01

OTHER EVENTS

The current stock ledger from the Company’s Transfer Agent, Transhare Corporation, reflects the common share structure of issued and outstanding at 16,127,194 shares. Of these, 14,037,194 are restricted and of the remaining 2,090,000, 1,015,866 are currently on deposit.

ITEM 9.01

FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

Exhibit Number	Description

5.03	Designations of Preferred Class A and B shares

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



	SIBANNAC, INC.
Date: May 19, 2020	By: /s/ David Mersky
		David Mersky
		Chief Executive Officer

Sibannac, Inc. 8-K